Comprehensive Evaluation of Endocytosis-Associated Protein SCAMP3 in Hepatocellular Carcinoma

References

• Naboulsi W, Bracht T, Megger DA, et al. Quantitative proteome analysis reveals the correlation between endocytosis-associated proteins and hepatocellular carcinoma dedifferentiation. Biochim Biophys Acta. 2016;1864(11):1579–1585. doi:10.1016/j.bbapap.2016.08.00527519163
   PubMed Web of Science ®Google Scholar
• Skawran B, Steinemann D, Weigmann A, et al. Gene expression profiling in hepatocellular carcinoma: upregulation of genes in amplified chromosome regions. Mod Pathol. 2008;21(5):505–516. doi:10.1038/modpathol.380099818277965
   PubMed Web of Science ®Google Scholar
• Thomas P, Wohlford D, Aoh QL. SCAMP 3 is a novel regulator of endosomal morphology and composition. Biochem Biophys Res Commun. 2016;478(3):1028–1034. doi:10.1016/j.bbrc.2016.08.01227507217
   PubMed Web of Science ®Google Scholar
• Aoh QL, Castle AM, Hubbard CH, Katsumata O, Castle JD. SCAMP3 negatively regulates epidermal growth factor receptor degradation and promotes receptor recycling. Mol Biol Cell. 2009;20(6):1816–1832. doi:10.1091/mbc.E08-09-089419158374
   PubMed Web of Science ®Google Scholar
• Chunliu L, Zhang Z, Peng L, Zhan Y, Zhong Q. SCAMP3 promotes glioma proliferation and indicates unfavorable prognosis via multiple pathways. Onco Targets Ther. 2020;13:3677–3687. doi:10.2147/OTT.S24246232431518
   PubMed Web of Science ®Google Scholar
• Suárez-Arroyo IJ, Feliz-Mosquea YR, Pérez-Laspiur J, et al. The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease. Am J Cancer Res. 2016;6(8):1720–1740.27648361
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Rodriguez IP. UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia. 2017;19(8):649–658. doi:10.1016/j.neo.2017.05.00228732212
   PubMed Web of Science ®Google Scholar
• Tang Z, Kang B, Chenwei L, Chen T, Zhang Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556–W560. doi:10.1093/nar/gkz43031114875
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92–D97. doi:10.1093/nar/gkt124824297251
   PubMed Web of Science ®Google Scholar
• Yang JH, Li JH, Shao P, Zhou H, Chen YQ, Qu LH. starBase: a database for exploring microRNA-mRNA interaction maps from argonaute CLIP-Seq and degradome-seq data. Nucleic Acids Res. 2011;39:D202–D209. doi:10.1093/nar/gkq105621037263
   PubMed Web of Science ®Google Scholar
• Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia. 2004;6(1):1–6. doi:10.1016/S1476-5586(04)80047-215068665
   PubMed Web of Science ®Google Scholar
• Menyhart O, Nagy A, Gyorffy B. Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma. R Soc Open Sci. 2018;5(122):181006. doi:10.1098/rsos.18100630662724
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47:D607–D613. doi:10.1093/nar/gky113130476243
   PubMed Web of Science ®Google Scholar
• Oughtred R, Stark C, Breitkreutz BJ, et al. The BioGRID interaction database: 2019 update. Nucleic Acids Res. 2019;47(D1):D529–D541. doi:10.1093/nar/gky107930476227
   PubMed Web of Science ®Google Scholar
• Cheng L, Wang P, Tian R, et al. Lncrna2target V2.0: a comprehensive database for target genes of lncrnas in human and mouse. Nucleic Acids Res. 2018;gky1051–gky51.
   Web of Science ®Google Scholar
• Dweep H, Sticht C, Pandey P, Gretz N. miRWalk-database: prediction of possible miRNA binding sites by ‘walking’ the genes of three genomes. J Biomed Inform. 2011;44:839–847. doi:10.1016/j.jbi.2011.05.00221605702
   PubMed Web of Science ®Google Scholar
• Betel D, Koppal A, Agius P, Sander C, Leslie C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. 2010;11(8):R90. doi:10.1186/gb-2010-11-8-r9020799968
   PubMed Web of Science ®Google Scholar
• Wong N, Wang X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 2015;43(Database issue):D146–D152. doi:10.1093/nar/gku110425378301
   PubMed Web of Science ®Google Scholar
• Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. Elife. 2015;4. doi:10.7554/eLife.05005
   Web of Science ®Google Scholar
• Paraskevopoulou MD, Vlachos IS, Karagkouni D, et al. DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts. Nucl Acids Res. 2016;gkv1270.
   Google Scholar
• Ghosh D, Ulasov IV, Chen L, et al. TGFβ-responsive HMOX1 expression is associated with stemness and invasion in glioblastoma multiforme. Stem Cells. 2016;34(9):2276–2289. doi:10.1002/stem.241127354342
   PubMed Web of Science ®Google Scholar
• Normanno N, De Luca A, Bianco C, et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 2006;366(1):2–16. doi:10.1016/j.gene.2005.10.01816377102
   PubMed Web of Science ®Google Scholar
• Pilling C, Cooper JA. SOCS2 binds to and regulates EphA2 through multiple mechanisms. Sci Rep. 2017;7(1):10838. doi:10.1038/s41598-017-11040-328883622
   PubMed Web of Science ®Google Scholar
• Qiu X, Zheng J, Guo X, et al. Reduced expression of SOCS2 and SOCS6 in hepatocellular carcinoma correlates with aggressive tumor progression and poor prognosis. Mol Cell Biochem. 2013;378(1–2):99–106. doi:10.1007/s11010-013-1599-523475171
   PubMed Web of Science ®Google Scholar
• Cui M, Sun J, Hou J, et al. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma. Tumour Biol. 2016;37(10):13521–13531. doi:10.1007/s13277-016-5215-727465557
   PubMedGoogle Scholar
• Vesterlund M, Zadjali F, Persson T, et al. The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels. PLoS One. 2011;6(9):e25358. doi:10.1371/journal.pone.002535821980433
   PubMed Web of Science ®Google Scholar
• Li Y, Liu G, Li X, Dong H, Xiao W, Lu S. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway. Biochem Biophys Res Commun. 2018;503(4):2826–2832. doi:10.1016/j.bbrc.2018.08.04730115383
   PubMed Web of Science ®Google Scholar
• Zhang YT, Li BP, Zhang B, et al. LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis. Eur Rev Med Pharmacol Sci. 2018;22(19):6333–6341. doi:10.26355/eurrev_201810_1604430338801
   PubMed Web of Science ®Google Scholar
• Noh JH, Chang YG, Kim MG, et al. MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer. Cancer Lett. 2013;335(2):455–462. doi:10.1016/j.canlet.2013.03.00323499894
   PubMed Web of Science ®Google Scholar
• Duan X, Hu J, Wang Y, Gao J, Peng D, Xia L. MicroRNA-145: a promising biomarker for hepatocellular carcinoma (HCC). Gene. 2014;541(1):67–68. doi:10.1016/j.gene.2014.03.01824630966
   PubMed Web of Science ®Google Scholar